Sex- and Age-Related Variations in Symptoms and Signs of Dupilumab-Associated Ocular Surface Diseases in Colombian Patients
{{output}}
Background: Dupilumab, approved for treating moderate-to-severe atopic dermatitis (AD), has been linked to a group of ocular surface adverse effects collectively called dupilumab-associated ocular surface diseases (DAOSDs). Altho... ...
